No Supply Issues With Ivermectin: Pharmaceutical Supplying PRINCIPLE Oxford Trial

Click here to read the full article.

The New Jersey pharmaceutical company supplying ivermectin to a UK trial that was paused for a short period of time, says there are no supply issues with its pills.

Ivermectin is being investigated as part of the government-backed Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE) in the United Kingdom as a possible home treatment for COVID-19, the disease caused by the CCP (Chinese Communist Party) virus. The trial was put on hold due to “temporary supply issues” as reported by Medpage Today on Dec. 14.

Details were not provided on the cause of the supply issues. The trial’s joint chief investigator, professor Chris Butler, and the trial’s press team declined to comment and respond to a query asking when the supply issue is expected to be resolved.

Continue reading here.

Scroll down for comments and share what’s on your mind.

What do you think?

Leave a Reply

Your email address will not be published.

GIPHY App Key not set. Please check settings

US Navy Warship Pauses Deployment After COVID-19 Outbreak Among ‘100 Percent Immunized’ Crew

Head of US Energy Alliance Says Biden Administration’s Energy Policies Are Driving up Costs of Oil and Gas